Gufic Receives Dcgi Nod For Thymosin Alpha - 1
05/04/2022 12:26
Gufic Biosciences Ltd GUFI.NS :
* GUFIC BIOSCIENCES LTD - GUFIC RECEIVES DCGI NOD FOR
THYMOSIN
ALPHA - 1
* GUFIC BIOSCIENCES LTD - THYMOSIN ALPHA-1 IS ADD-ON THERAPY
FOR
TREATMENT OF MODERATE-TO-SEVERE COVID-19 PATIENTS REQUIRING
VENTILATOR SUPPORT
Source text for Eikon: ID:nBSE81PXmk
Further company coverage: GUFI.NS
Recent news on Gufic Biosciences
See all newsBrief: Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility
Brief: Gufic Biosciences June-Quarter Consol Total Profit 223.1 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences posts Sept-Quarter Consol Revenue From Operations 2.37 Billion Rupees